ACE and hydrops fetalis: Patients in groups 2 and 3 received the recommended therapy for HF: 77-90% angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor antagonists (ARA), 77-90% beta-blockers, 55-61% mineralocorticoid receptor antagonists (MRA), and 100% diuretics.